Although testicular microenvironment and pathology differ from the tumoral, considering the high potential of p53 to be targeted for drug therapy, insights into the interplay between p53 and spermatogenesis and male infertility are needed, which opens up avenues for novel p53-based therapeutic interventions. This evidence concerns the gene TP53 and male infertility.